The PTPN22 C1858T gene variant is associated with proinsulin in new-onset type 1 diabetes

Lotte B Nielsen, Sven Pörksen, Marie Louise M Andersen, Siri Fredheim, Jannet Svensson, Philip Hougaard, Maurizio Vanelli, Jan Åman, Henrik B Mortensen, Lars Hansen, Hvidoere Study Group on Childhood Diabetes

18 Citationer (Scopus)

Abstract

The protein tyrosine phosphatase nonreceptor type 2 (PTPN22) has been established as a type 1 diabetes susceptibility gene. A recent study found the C1858T variant of this gene to be associated with lower residual fasting C-peptide levels and poorer glycemic control in patients with type 1 diabetes. We investigated the association of the C1858T variant with residual beta-cell function (as assessed by stimulated C-peptide, proinsulin and insulin dose-adjusted HbA1c), glycemic control, daily insulin requirements, diabetic ketoacidosis (DKA) and diabetes-related autoantibodies (IA-2A, GADA, ICA, ZnT8Ab) in children during the first year after diagnosis of type 1 diabetes.
OriginalsprogEngelsk
TidsskriftB M C Medical Genetics
Vol/bind12
Sider (fra-til)41
ISSN1471-2350
DOI
StatusUdgivet - 2011

Fingeraftryk

Dyk ned i forskningsemnerne om 'The PTPN22 C1858T gene variant is associated with proinsulin in new-onset type 1 diabetes'. Sammen danner de et unikt fingeraftryk.

Citationsformater